What do you do if you think you have VITT? What we know of the rare clotting disorder
|CTVnews 04 May 2021 at 17:06|
A new blood-clotting syndrome seen in a small minority of COVID-19 vaccine recipients continues to draw significant attention, but experts maintain the event is exceedingly rare -- and treatable, in most cases.
Vaccine-induced thrombotic thrombocytopenia, or VITT, has been identified in a handful of Oxford-AstraZeneca recipients in Canada, causing death in one patient.
Dr. Jeff Weitz, the executive director of the Thrombosis and Atherosclerosis Research Institute (TAARI) at McMaster University, says doctors are learning more about VITT every day.
And that s good news for those worried about potentially developing the disorder.
"We now know how to diagnose this and we know how to treat it," Weitz said. "So even if you are one of those unfortunate, rare individuals -- maybe four out of a million -- who get it, we know what to do."
Experts maintain the benefits of vaccinations far outweigh the small risk of the clots, with Weitz noting that clots have been detected far more often in COVID-19 patients.